ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesions (MIB295)
NICE has developed a medtech innovation briefing (MIB) on ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesions
Search results
19 results
-
-
Granulox for managing chronic non-healing wounds (MIB296)
NICE has developed a medtech innovation briefing (MIB) on Granulox for managing chronic non-healing wounds
-
AMBLor for identifying low-risk non-ulcerated early-stage cutaneous melanomas (MIB294)
NICE has developed a medtech innovation briefing (MIB) on AMBLor for identifying low-risk non-ulcerated early-stage cutaneous melanomas
-
Bladder EpiCheck for detecting bladder cancer recurrence (MIB293)
NICE has developed a medtech innovation briefing (MIB) on Bladder EpiCheck for detecting bladder cancer recurrence
-
icobrain ms for active relapsing–remitting multiple sclerosis (MIB291)
NICE has developed a medtech innovation briefing (MIB) on icobrain ms for active relapsing–remitting multiple sclerosis
-
Artificial intelligence for analysing chest X-ray images (MIB292)
NICE has developed a medtech innovation briefing (MIB) on artificial intelligence for analysing chest X-ray images
-
Genedrive MT-RNR1 ID System for detecting single nucleotide polymorphism m.1555A G in newborn babies (MIB290)
NICE has developed a medtech innovation briefing (MIB) on Genedrive MT-RNR1 ID System for detecting single nucleotide polymorphism m.1555A>G in newborn babies
-
SecurePort IV tissue adhesive for use with percutaneous catheters (MIB288)
NICE has developed a medtech innovation briefing (MIB) on SecurePort IV tissue adhesive for use with percutaneous catheters
-
YOURmeds for medication support in long-term conditions (MIB289)
NICE has developed a medtech innovation briefing (MIB) on YOURmeds for medication support in long-term conditions
-
Lumella point-of-care test for assessing pre-eclampsia risk (MIB287)
NICE has developed a medtech innovation briefing (MIB) on Lumella point-of-care test for assessing pre-eclampsia risk
-
The Insides System for managing intestinal failure (MIB286)
NICE has developed a medtech innovation briefing (MIB) on The Insides System for managing intestinal failure
-
d-Nav insulin management app for type 2 diabetes (MIB285)
NICE has developed a medtech innovation briefing (MIB) on d-Nav insulin management app for type 2 diabetes
-
GaitSmart assessment and vGym personalised exercise rehabilitation programme for people with gait and mobility issues (MIB283)
NICE has developed a medtech innovation briefing (MIB) on GaitSmart assessment and vGym personalised exercise rehabilitation programme for people with gait and mobility issues
-
AposHealth for knee osteoarthritis (MIB284)
NICE has developed a medtech innovation briefing (MIB) on AposHealth for knee osteoarthritis
-
Smart Peak Flow for monitoring asthma (MIB282)
NICE has developed a medtech innovation briefing (MIB) on Smart Peak Flow for monitoring asthma
-
FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndrome (MIB281)
NICE has developed a medtech innovation briefing (MIB) on FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress
-
clonoSEQ for minimal residual disease assessment in multiple myeloma, acute lymphoblastic leukaemia and chronic lymphocytic leukaemia (MIB278)
NICE has developed a medtech innovation briefing (MIB) on clonoSEQ for minimal residual disease assessment in multiple myeloma, acute lymphoblastic leukaemia
-
CerebAir for continuous EEG monitoring in intensive care (MIB279)
NICE has developed a medtech innovation briefing (MIB) on CerebAir for continuous EEG monitoring in intensive care
-
Paige Prostate for prostate cancer (MIB280)
NICE has developed a medtech innovation briefing (MIB) on Paige Prostate for prostate cancer